Palo Alto, CA, United States of America

Luiz Belardinelli

USPTO Granted Patents = 41 

 

 

Average Co-Inventor Count = 2.8

ph-index = 10

Forward Citations = 318(Granted Patents)


Location History:

  • Menlo Park, CA (US) (2003 - 2013)
  • Palo Alto, CA (US) (2006 - 2024)

Company Filing History:


Years Active: 2003-2024

Loading Chart...
Loading Chart...
Loading Chart...
41 patents (USPTO):Explore Patents

Title: Innovations in Cardiac Care: The Patents of Luiz Belardinelli

Introduction

Luiz Belardinelli, an accomplished inventor based in Palo Alto, California, has made significant contributions to the field of cardiac care, holding a remarkable 41 patents. His groundbreaking work focuses on novel methods and formulations for treating heart conditions, particularly those related to cardiac arrhythmias.

Latest Patents

Among Belardinelli's latest inventions are methods and kits for the induction of cardioversion in subjects experiencing atrial arrhythmias. These patents disclose innovative approaches that utilize potassium channel inhibitors and class I antiarrhythmic agents to treat or prevent heart conditions. Additionally, he has developed methods to deliver a fixed-dose combination of sodium channel blockers and antiarrhythmic agents through various administration routes, including intravenous, oral, and inhalational methods. He also introduced an antiarrhythmic formulation as a pharmaceutical composition for treating heart conditions via inhalation. This includes nebulized drug products and kits, emphasizing his commitment to advancing therapeutic options in cardiology.

Career Highlights

Throughout his career, Luiz Belardinelli has worked with leading companies in the biopharmaceutical field, including Gilead Sciences, Inc. and Cv Therapeutics, Inc. His work in these organizations has enabled him to further refine his inventions and contribute to the development of innovative treatments for patients suffering from cardiovascular issues.

Collaborations

Belardinelli has collaborated with notable colleagues in his field, including Jeff A. Zablocki and Dewan Zeng. These partnerships have facilitated knowledge-sharing and accelerated the progression of their collective work in medical innovation.

Conclusion

Luiz Belardinelli continues to be a pivotal figure in cardiac care innovation with his extensive portfolio of patents. His contributions are not only advancing treatments for heart conditions but are also improving the quality of life for patients worldwide. As his research and developments progress, the impact of his work will undoubtedly resonate within the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…